223 related articles for article (PubMed ID: 33031325)
21. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
[TBL] [Abstract][Full Text] [Related]
22. Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review.
Dai P; Ye Z; Cai Z; Luo Z; Qiu E; Lin Y; Cai J; Wang H; Li Z; Han S
BMC Gastroenterol; 2022 Feb; 22(1):65. PubMed ID: 35164703
[TBL] [Abstract][Full Text] [Related]
23. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
24. Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Somashekhar SP; Yethadka R; Kumar C R; Ashwin KR; Zaveri S; Rauthan A
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):577-581. PubMed ID: 31677939
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J
Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852
[TBL] [Abstract][Full Text] [Related]
26. Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology.
van Oudheusden TR; Braam HJ; Nienhuijs SW; Wiezer MJ; van Ramshorst B; Luyer P; de Hingh IH
J Surg Oncol; 2015 Feb; 111(2):237-42. PubMed ID: 25195780
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study.
Tang L; Mei LJ; Yang XJ; Huang CQ; Zhou YF; Yonemura Y; Li Y
J Transl Med; 2011 May; 9():53. PubMed ID: 21548973
[TBL] [Abstract][Full Text] [Related]
28. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience.
Deraco M; Sinukumar S; Salcedo-Hernández RA; Rajendra VJ; Baratti D; Guaglio M; Nizri E; Kusamura S
Eur J Surg Oncol; 2019 Nov; 45(11):2103-2108. PubMed ID: 31230982
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
Shi C; Yang B; Chen Q; Yang J; Fan N
Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
[TBL] [Abstract][Full Text] [Related]
30. Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study.
Tu Y; Tian Y; Fang Z; Ruan Q; Tang H; Zhang X; Wu Y; Ding Y; Cui S
Int J Hyperthermia; 2016 Sep; 32(6):587-94. PubMed ID: 27362668
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G
Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159
[TBL] [Abstract][Full Text] [Related]
32. Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.
Magge D; Zenati M; Mavanur A; Winer J; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2014 May; 21(5):1448-55. PubMed ID: 24197761
[TBL] [Abstract][Full Text] [Related]
33. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
34. P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Yong ZZ; Tan GHC; Shannon N; Chia C; Teo MCC
World J Surg Oncol; 2019 Aug; 17(1):138. PubMed ID: 31391066
[TBL] [Abstract][Full Text] [Related]
35. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.
Lopez-Ramirez F; Gushchin V; Sittig M; King MC; Baron E; Nikiforchin A; Nieroda C; Sardi A
Ann Surg Oncol; 2022 Jun; 29(6):3390-3401. PubMed ID: 35133518
[TBL] [Abstract][Full Text] [Related]
36. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer.
Liu L; Sun L; Zhang N; Liao CG; Su H; Min J; Song Y; Yang X; Huang X; Chen D; Chen Y; Zhang HW; Zhang H
Int J Hyperthermia; 2022; 39(1):239-245. PubMed ID: 35100917
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report.
Du XM; Wei YP; Gao Y; Li Z; Zhang JM; Chang H; Li Y
Medicine (Baltimore); 2021 Mar; 100(12):e25264. PubMed ID: 33761726
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]